Advertisement

Index by Author

December 1986; 35 (12)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aitken, P M

    • Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes December 1986 35:1383-1389; doi:10.2337/diabetes.35.12.1383

  2. Alamo, A

    • Lymphocyte subsets and activation in prediabetes. Diabetes December 1986 35:1416-1422; doi:10.2337/diabetes.35.12.1416

  3. Alford, F P

    • Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes December 1986 35:1383-1389; doi:10.2337/diabetes.35.12.1383

  4. Ammon, H P

    • Cysteine analogues potentiate glucose-induced insulin release in vitro. Diabetes December 1986 35:1390-1396; doi:10.2337/diabetes.35.12.1390

B

  1. Best, J D

    • Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes December 1986 35:1383-1389; doi:10.2337/diabetes.35.12.1383

  2. Boston, R C

    • Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes December 1986 35:1383-1389; doi:10.2337/diabetes.35.12.1383

  3. Brolin, S E

    • Increased accumulation of sorbitol in offspring of manifest diabetic rats. Diabetes December 1986 35:1356-1363; doi:10.2337/diabetes.35.12.1356

C

  1. Campbell, P J

    • Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes December 1986 35:1326-1331; doi:10.2337/diabetes.35.12.1326

  2. Carpentier, J L

    • Diacylglycerol modulation of insulin receptor from cultured human mononuclear cells. Effects on binding and internalization. Diabetes December 1986 35:1364-1370; doi:10.2337/diabetes.35.12.1364

  3. Constable, I J

    • Prevalence of diabetic complications in relation to risk factors. Diabetes December 1986 35:1332-1339; doi:10.2337/diabetes.35.12.1332

E

  1. Enz, G

    • Cysteine analogues potentiate glucose-induced insulin release in vitro. Diabetes December 1986 35:1390-1396; doi:10.2337/diabetes.35.12.1390

  2. Eriksson, U J

    • Increased accumulation of sorbitol in offspring of manifest diabetic rats. Diabetes December 1986 35:1356-1363; doi:10.2337/diabetes.35.12.1356

  3. Ernst, E

    • Altered red and white blood cell rheology in type II diabetes. Diabetes December 1986 35:1412-1415; doi:10.2337/diabetes.35.12.1412

  4. Estilow, S

    • Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats. Diabetes December 1986 35:1309-1313; doi:10.2337/diabetes.35.12.1309

  5. Eto, M

    • Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes December 1986 35:1374-1382; doi:10.2337/diabetes.35.12.1374

F

  1. Forman, L J

    • Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats. Diabetes December 1986 35:1309-1313; doi:10.2337/diabetes.35.12.1309

G

  1. Gerich, J E

    • Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes December 1986 35:1326-1331; doi:10.2337/diabetes.35.12.1326

  2. Gorden, P

    • Diacylglycerol modulation of insulin receptor from cultured human mononuclear cells. Effects on binding and internalization. Diabetes December 1986 35:1364-1370; doi:10.2337/diabetes.35.12.1364

  3. Groop, L C

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

  4. Groop, P H

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

  5. Grunberger, G

    • Diacylglycerol modulation of insulin receptor from cultured human mononuclear cells. Effects on binding and internalization. Diabetes December 1986 35:1364-1370; doi:10.2337/diabetes.35.12.1364

H

  1. Heggie, J C

    • Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes December 1986 35:1383-1389; doi:10.2337/diabetes.35.12.1383

  2. Hehl, K H

    • Cysteine analogues potentiate glucose-induced insulin release in vitro. Diabetes December 1986 35:1390-1396; doi:10.2337/diabetes.35.12.1390

  3. Hitchcock, C L

    • Lymphocyte subsets and activation in prediabetes. Diabetes December 1986 35:1416-1422; doi:10.2337/diabetes.35.12.1416

  4. Hösl, W

    • Maturation of immune response to insulin. Recruitment of new epitopes by antibodies. Diabetes December 1986 35:1321-1325; doi:10.2337/diabetes.35.12.1321

I

  1. Iacopetta, B

    • Diacylglycerol modulation of insulin receptor from cultured human mononuclear cells. Effects on binding and internalization. Diabetes December 1986 35:1364-1370; doi:10.2337/diabetes.35.12.1364

  2. Ionescu, E

    • Mechanism of abnormal oral glucose tolerance of genetically obese fa/fa rats. Diabetes December 1986 35:1350-1355; doi:10.2337/diabetes.35.12.1350

  3. Ishii, K

    • Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes December 1986 35:1374-1382; doi:10.2337/diabetes.35.12.1374

  4. Iwashima, Y

    • Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes December 1986 35:1374-1382; doi:10.2337/diabetes.35.12.1374

J

  1. Jakobsen, J

    • Decreased blood-brain barrier permeability to sodium in early experimental diabetes. Diabetes December 1986 35:1371-1373; doi:10.2337/diabetes.35.12.1371

  2. Jeanrenaud, B

    • Mechanism of abnormal oral glucose tolerance of genetically obese fa/fa rats. Diabetes December 1986 35:1350-1355; doi:10.2337/diabetes.35.12.1350

  3. Juhler, M

    • Decreased blood-brain barrier permeability to sodium in early experimental diabetes. Diabetes December 1986 35:1371-1373; doi:10.2337/diabetes.35.12.1371

K

  1. Karam, J H

    • Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM. Diabetes December 1986 35:1314-1320; doi:10.2337/diabetes.35.12.1314

  2. Kennedy, F P

    • Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes December 1986 35:1326-1331; doi:10.2337/diabetes.35.12.1326

  3. Kerp, L

    • Maturation of immune response to insulin. Recruitment of new epitopes by antibodies. Diabetes December 1986 35:1321-1325; doi:10.2337/diabetes.35.12.1321

  4. Kirsner, R L

    • Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes December 1986 35:1383-1389; doi:10.2337/diabetes.35.12.1383

  5. Knudsen, G M

    • Decreased blood-brain barrier permeability to sodium in early experimental diabetes. Diabetes December 1986 35:1371-1373; doi:10.2337/diabetes.35.12.1371

  6. Knuiman, M W

    • Prevalence of diabetic complications in relation to risk factors. Diabetes December 1986 35:1332-1339; doi:10.2337/diabetes.35.12.1332

  7. Kontiainen, S

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

  8. Koskimies, S

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

L

  1. Lafferty, K J

    • Reversal of diabetes in outbred mice by islet allotransplantation. Diabetes December 1986 35:1345-1349; doi:10.2337/diabetes.35.12.1345

  2. Lewis, M

    • Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats. Diabetes December 1986 35:1309-1313; doi:10.2337/diabetes.35.12.1309

M

  1. Maclaren, N K

    • Lymphocyte subsets and activation in prediabetes. Diabetes December 1986 35:1416-1422; doi:10.2337/diabetes.35.12.1416

  2. Manning, C D

    • Glucose transport by radiation-induced insulinoma and clonal pancreatic beta-cells. Diabetes December 1986 35:1340-1344; doi:10.2337/diabetes.35.12.1340

  3. Marangou, A G

    • Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes December 1986 35:1383-1389; doi:10.2337/diabetes.35.12.1383

  4. Matikainen, E

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

  5. Matrai, A

    • Altered red and white blood cell rheology in type II diabetes. Diabetes December 1986 35:1412-1415; doi:10.2337/diabetes.35.12.1412

  6. Matschinsky, F M

    • Glucose transport by radiation-induced insulinoma and clonal pancreatic beta-cells. Diabetes December 1986 35:1340-1344; doi:10.2337/diabetes.35.12.1340

  7. McCann, V J

    • Prevalence of diabetic complications in relation to risk factors. Diabetes December 1986 35:1332-1339; doi:10.2337/diabetes.35.12.1332

  8. Meglasson, M D

    • Glucose transport by radiation-induced insulinoma and clonal pancreatic beta-cells. Diabetes December 1986 35:1340-1344; doi:10.2337/diabetes.35.12.1340

  9. Miles, J M

    • Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes December 1986 35:1326-1331; doi:10.2337/diabetes.35.12.1326

  10. Morikawa, A

    • Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes December 1986 35:1374-1382; doi:10.2337/diabetes.35.12.1374

N

  1. Naeser, P

    • Increased accumulation of sorbitol in offspring of manifest diabetic rats. Diabetes December 1986 35:1356-1363; doi:10.2337/diabetes.35.12.1356

  2. Najafi, H

    • Glucose transport by radiation-induced insulinoma and clonal pancreatic beta-cells. Diabetes December 1986 35:1340-1344; doi:10.2337/diabetes.35.12.1340

  3. Nolte, M S

    • Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM. Diabetes December 1986 35:1314-1320; doi:10.2337/diabetes.35.12.1314

  4. Nurjhan, N

    • Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes December 1986 35:1326-1331; doi:10.2337/diabetes.35.12.1326

O

  1. Oshima, E

    • Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes December 1986 35:1374-1382; doi:10.2337/diabetes.35.12.1374

P

  1. Paulson, O B

    • Decreased blood-brain barrier permeability to sodium in early experimental diabetes. Diabetes December 1986 35:1371-1373; doi:10.2337/diabetes.35.12.1371

  2. Petersen, K G

    • Maturation of immune response to insulin. Recruitment of new epitopes by antibodies. Diabetes December 1986 35:1321-1325; doi:10.2337/diabetes.35.12.1321

  3. Proietto, J

    • Mechanism of abnormal oral glucose tolerance of genetically obese fa/fa rats. Diabetes December 1986 35:1350-1355; doi:10.2337/diabetes.35.12.1350

  4. Prowse, S J

    • Reversal of diabetes in outbred mice by islet allotransplantation. Diabetes December 1986 35:1345-1349; doi:10.2337/diabetes.35.12.1345

  5. Pyka, R

    • Lymphocyte subsets and activation in prediabetes. Diabetes December 1986 35:1416-1422; doi:10.2337/diabetes.35.12.1416

R

  1. Riley, W J

    • Lymphocyte subsets and activation in prediabetes. Diabetes December 1986 35:1416-1422; doi:10.2337/diabetes.35.12.1416

  2. Rohner-Jeanrenaud, F

    • Mechanism of abnormal oral glucose tolerance of genetically obese fa/fa rats. Diabetes December 1986 35:1350-1355; doi:10.2337/diabetes.35.12.1350

S

  1. Salamon, E

    • Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM. Diabetes December 1986 35:1314-1320; doi:10.2337/diabetes.35.12.1314

  2. Sanz, N

    • Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM. Diabetes December 1986 35:1314-1320; doi:10.2337/diabetes.35.12.1314

  3. Scheinin, T

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

  4. Schuler, G

    • Maturation of immune response to insulin. Recruitment of new epitopes by antibodies. Diabetes December 1986 35:1321-1325; doi:10.2337/diabetes.35.12.1321

  5. Sekiguchi, M

    • Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes December 1986 35:1374-1382; doi:10.2337/diabetes.35.12.1374

  6. Setiadi-Ranti, A

    • Cysteine analogues potentiate glucose-induced insulin release in vitro. Diabetes December 1986 35:1390-1396; doi:10.2337/diabetes.35.12.1390

  7. Simeonovic, C J

    • Reversal of diabetes in outbred mice by islet allotransplantation. Diabetes December 1986 35:1345-1349; doi:10.2337/diabetes.35.12.1345

  8. Stanton, K G

    • Prevalence of diabetic complications in relation to risk factors. Diabetes December 1986 35:1332-1339; doi:10.2337/diabetes.35.12.1332

  9. Storch, M J

    • Maturation of immune response to insulin. Recruitment of new epitopes by antibodies. Diabetes December 1986 35:1321-1325; doi:10.2337/diabetes.35.12.1321

T

  1. Teir, H

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

  2. Teppo, A M

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

  3. Tolppanen, E M

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

V

  1. Vasilenko, P

    • Streptozocin diabetes alters immunoreactive beta-endorphin levels and pain perception after 8 wk in female rats. Diabetes December 1986 35:1309-1313; doi:10.2337/diabetes.35.12.1309

  2. Verkkala, E

    • Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes December 1986 35:1397-1403; doi:10.2337/diabetes.35.12.1397

  3. Verspohl, E J

    • Cysteine analogues potentiate glucose-induced insulin release in vitro. Diabetes December 1986 35:1390-1396; doi:10.2337/diabetes.35.12.1390

W

  1. Watanabe, K

    • Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes December 1986 35:1374-1382; doi:10.2337/diabetes.35.12.1374

  2. Weber, K M

    • Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes December 1986 35:1383-1389; doi:10.2337/diabetes.35.12.1383

  3. Welborn, T A

    • Prevalence of diabetic complications in relation to risk factors. Diabetes December 1986 35:1332-1339; doi:10.2337/diabetes.35.12.1332

  4. Wellhausen, S R

    • Definition of streptozocin toxicity for primary lymphoidal tissues. Diabetes December 1986 35:1404-1411; doi:10.2337/diabetes.35.12.1404

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement